库尔库明的机制洞察:的潜在药理学候选者
1Department of Obstetrics, Gynecology and Reproductive Sciences, School of Medicine, University of Maryland, Baltimore, MD, United States.
Frontiers in pharmacology
|January 23, 2025
概括
黄素通过调节大脑炎症和表观遗传变化,在治疗方面表现有前途. 纳米化增强了库尔库明的作用.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
背景情况:
- 的特点是经常性发作,目前的抗药 (AED) 提供了不充分的治疗和显著的不良影响.
- 开发针对潜在机制而没有副作用的新疗法是管理中的一个关键挑战.
- 植物成分,特别是黄素,正因其在中枢神经系统疾病中的神经调节潜力而引起人们的注意.
研究的目的:
- 审查黄素对发发生过程中关键生物标志物的调节作用.
- 探索纳米化在提高黄素在治疗中的大脑生物可用性方面的潜力.
主要方法:
- 对黄素神经保护和免疫调节作用的临床前和临床研究的综述.
- 分析黄素对信号通路,氧化应激,亡,炎症和表观遗传修饰 (基因组乙化/脱乙化) 的影响.
- 检查旨在改善黄素的药理动力学特征的纳米载体系统.
主要成果:
- 黄素通过调节炎症机制,氧化应激和亡来显示神经保护性质.
- 黄素影响表观遗传变化,包括基因素修饰,可能影响与发性相关的基因表达.
- 纳米化策略对于克服黄素低大脑生物可用性至关重要.
结论:
- 黄素是的有希望的治疗候选物,因为它对发生的多方面调节作用.
- 用黄素准免疫细胞,细胞因子和表观遗传因素等生物标志物提供了一个新的治疗途径.
- 像纳米载体这样的先进的药物输送系统对于实现中黄素的全部治疗潜力至关重要.
相关概念视频
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
316
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
316
01:14Antiepileptic Drugs: Glutamate Antagonists
273
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
273
01:24Arteries of the Lower Limbs
177
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
177
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
224
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
224
01:20Antiepileptic Drugs: Potassium Channel Activators
142
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
142
01:17Antiepileptic Drugs: Calcium Channel Blockers
299
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
299